HARROW, INC. — Director's Dealing 2012

Apr 28, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-01-23

Reporting Person: Brar Balbir (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	16717	Direct
Common Stock	49305	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (Right to Buy)	$0.74	2016-01-22	Common Stock (1125000)		Direct
Option (Right to Buy)	$0.9	2017-03-31	Common Stock (125000)		Direct

Footnotes

F1: Mr. Balbir Brar is the trustee of the Balbir S Brar TTY Trust and may be deemed to have voting and dispositive power the 49,305 shares of Common Stock owned by the Balbir S Brar TTY Trust. Mr. Brar disclaim beneficial ownership over such shares.

F2: The stock options, granted on January 23, 2012 and effective as of February 28, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Mr. Brar's options vest over a 4 year period at a strike price of $0.74, with 1/36 of the total number of options vesting each monthly period following the grant date of the issuance of such options. As of the date of this Form 3 filing, options to purchase 156,250 shares of the Issuer's common stock are exercisable, but no options have been exercised.

F3: The stock options, granted on April 1, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Mr. Brar's options maintain a strike price of $0.90, and vest quarterly over a one year term with the initial 31,250 options vesting on June 30, 2012, the next 31,250 options vesting on September 30, 2012, the next 31,250 options vesting on December 31, 2012 and the final 31,250 options vesting on March 31, 2013.